| The knowledge-gradient algorithm for sequencing experiments in drug discovery DM Negoescu, PI Frazier, WB Powell INFORMS Journal on Computing 23 (3), 346-363, 2011 | 189 | 2011 |
| Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis DE Winetsky, DM Negoescu, EH DeMarchis, O Almukhamedova, ... PLoS medicine 9 (11), e1001348, 2012 | 87 | 2012 |
| Dynamic learning of patient response types: An application to treating chronic diseases DM Negoescu, K Bimpikis, ML Brandeau, DA Iancu Management science 64 (8), 3469-3488, 2018 | 69 | 2018 |
| Proactive vs reactive therapeutic drug monitoring of infliximab in Crohn’s disease: a cost-effectiveness analysis in a simulated cohort DM Negoescu, EA Enns, B Swanhorst, B Baumgartner, JP Campbell, ... Inflammatory bowel diseases 26 (1), 103-111, 2020 | 44 | 2020 |
| Design of incentive programs for optimal medication adherence in the presence of observable consumption S Suen, D Negoescu, J Goh Operations Research 70 (3), 1691-1716, 2022 | 14 | 2022 |
| Public/Private Partnerships in transit: Case studies and analysis M Blodgett, A Khani, D Negoescu, S Benjaafar Minnesota Council on Transportation Access, 2017 | 10 | 2017 |
| Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? DM Negoescu, DK Owens, ML Brandeau, E Bendavid Clinical infectious diseases 55 (10), 1392-1399, 2012 | 9 | 2012 |
| Design of incentive programs for optimal medication adherence S Suen, D Negoescu, J Goh Available at SSRN 3308510, 2018 | 7 | 2018 |
| Differentiated human immunodeficiency virus RNA monitoring in resource-limited settings: an economic analysis DM Negoescu, Z Zhang, HC Bucher, E Bendavid, Swiss HIV Cohort Study Clinical infectious diseases 64 (12), 1724-1730, 2017 | 7* | 2017 |
| Crystalcandle: A user-facing model explainer for narrative explanations J Yang, D Negoescu, P Ahammad arXiv preprint arXiv:2105.12941, 2021 | 3 | 2021 |
| When and what to test for: A cost-effectiveness analysis of febrile illness test-and-treat strategies in the era of responsible antibiotic use AZ Zhang, D Negoescu, C Munoz-Zanzi Plos one 15 (1), e0227409, 2020 | 3 | 2020 |
| Optimal learning for drug discovery in ewing’s sarchoma D Negoescu, P Frazier To appear, 2011 | 3 | 2011 |
| Does mothers’ and caregivers' access to information on their child’s vaccination card impact the timing of their child’s measles vaccination in Uganda? BC Griffith, SE Cusick, KM Searle, DM Negoescu, NE Basta, C Banura BMC public health 22 (1), 834, 2022 | 2 | 2022 |
| Intellige: A user-facing model explainer for narrative explanations J Yang, D Negoescu, P Ahammad arXiv preprint arXiv:2105.12941, 2021 | 2 | 2021 |
| Managing Uncertainty in Sequential Medical Decision Making DM Negoescu stanford university, 2014 | 1 | 2014 |
| Epsilon*: Privacy Metric for Machine Learning Models DM Negoescu, H Gonzalez, SEA Orjany, J Yang, Y Lut, R Tandra, ... arXiv preprint arXiv:2307.11280, 2023 | | 2023 |
| Sales Channel Optimization via Simulations Based on Observational Data with Delayed Rewards: A Case Study at LinkedIn DM Negoescu, P Khosravi, S Zhao, N Chen, P Ahammad, H Gonzalez arXiv preprint arXiv:2209.07749, 2022 | | 2022 |
| Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: Mathematical Modeling and Cost-Effectiveness Analysis D Negoescu, EA Enns, B Swanhorst, B Baumgartner, B Vaughn 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Cost-Effectiveness Analysis of Clinical Management Strategies for Undifferentiated Febrile Illness in the Era of Responsible Antibiotic Use Z Zhang, D Negoescu, C Munoz-Zanzi 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Optimal Learning for Drug Discovery in Ewing’s Sarcoma DMNPI Frazier | | 2009 |
